(All fields required)
Please enter a valid email.
Please enter your name.
The Clinical Translational Research Center (CTRC) provides
the resources and staff for the performance of a wide variety of research
studies. Our staff works with the investigator and study team to ensure the
success of the study and optimal care for the study subject and family. Learn more about our faculty and staff.
Mark M. Mitsnefes, MD, MS Pediatric Nephrologist
Professor, UC Department of Pediatrics
Nephrology with focus on chronic kidney disease and hypertension
Mark Mitsnefes, MD, MS, is an established clinical investigator with expertise in the area of understanding the development of risk factors for cardiovascular disease in children with chronic kidney disease. The long-term goal of his research is to define biologic targets for interventions to prevent and slow progression of cardiovascular disease in children with chronic kidney disease.
Dr. Misnefes has received numerous awards, including the Proctor Scolar Award (Cincinnati Children's Research Foundation), the Pediatrician Scientist Award (Children's Health Research Center, NIH), the Clinical Scientist Award (National Kidney Foundation), and has been ranked as one of the Best Doctors in America, 2007-2011.
MD: Gorky Medical Institute, Gorky, Russia, 1985.Residency: Miami Children's Hospital, Miami, Florida, 1997.Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 2000.
MS: Epidemiology and Biostatistics, University of Cincinnati, Cincinnati, Ohio, 2001.
Certifications: Educational Commission for Foreign Medical Graduates (ECFMG), 1995; Pediatrics, 1996; Pediatric Nephrology, 2001, 2008.
Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B; CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol. 2010 Jan;21(1):137-44.
Wilson AC, Mitsnefes MM. Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management. Am J Kidney Dis. 2009 Aug;54(2):345-60. Review.
Flynn JT, Mitsnefes MM, Pierce C, Cole SR, Parekh RS, Furth SL and Warady BA. Blood pressure in children with chronic kidney disease: Preliminary findings from chronic kidney disease in children cohort study. Hypertension. 2008;52(4):631-7
Weaver DJ Jr, Kimball T, Witt SA, Glascock BJ, Khoury PR, Kartal J, Mitsnefes MM. Subclinical systolic dysfunction in pediatric patients with chronic kidney disease. J Pediatr. 2008 Oct;153(4):565-9.
Weaver DJ Jr., Kimball TR, Knilans T, Mays WK, Knecht T, Gerdes YT, Witt S, Glascock BJ, Kartal J, Khoury PR, and Mitsnefes MM. Decreased maximal aerobic capacity in pediatric chronic kidney disease. J Am Soc Nephrol. 2008, 19(3):624-30.
Mitsnefes MM, Kimball TR, Kimball TR, Witt SA, Glascock BJ, Khoury PR, and Daniels SR. Abnormal carotid artery structure and function in children with successful renal transplant. Circulation. 2004; 110:97-101.
Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock B, Khoury PR, Daniels SR. Cardiac and vascular adaptation in pediatric patients with chronic kidney disease: Role of calcium-phosphorus metabolism. J Am Soc Nephrol. 2005;16:2796-2803.
Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR and Daniels SR. Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int. 2004;65(4):1461-1466.
Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, and Daniels SR. Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation. 2003;107:864-868
Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Meyer RA, and Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14:898-902.
Adiponectin and Cardiovascular Disease in the CKiD Children. Principal Investigator. National Institutes of Health. 2007 - 2011. #R01 DK076957.
Modify Dietary Behavior in Adolescents with Elevated Blood Pressure. Co-investigator. National Institutes of Health. 2007 - 2012.
Prospective study of chronic kidney disease in children. Co-investigator, Co-chair of the Cardiovascular Committee. National Institutes of Health. 2003 - 2013. #U01 DK-03-012.
Cardiovascular disease in children with CKD. Principal Investigator. National Institutes of Health. 2011 - 2016. #K24 DK090070-01.
Lara A. Danziger-Isakov, MD, MPH Director, Transplant ID
Director, Transplant ID
Associate Professor, UC Department of Pediatrics
Transplant infectious diseases
Dr. Danziger-Isakov began her research career investigating cytomegalovirus in pediatric lung transplant recipients. After completing fellowship she led an international epidemiological study of pediatric lung transplant recipients including 14 international sites from North America and Europe to publish seminal manuscripts on fungal and viral infections through the International Pediatric Lung Transplant Collaborative. While at the Cleveland Clinic she performed an innovative investigation evaluating alloreactive cellular and humoral responses to influenza vaccine in transplant recipients. She is the protocol chair for two NIH-funded pediatric transplant studies in the Clinical Trials in Organ Transplantation in Pediatrics (CTOT-C) entitled "Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03)" and "Perceived Barriers to Patient Adherence after Pediatric Solid Organ Transplantation (CTOTC-05)" with principal investigator Stuart Sweet at Washington University.
Dr. Danziger-Isakov is a member of several international organizations, with guest lectureships throughout the North America and Europe. She has been recognized with the Clinical Science Career Development Award from the American Society of Transplantation in 2012, has been elected as co-editor for the American Society of Transplantation’s 3rd Edition of the Infectious Diseases Guidelines, and served as Infectious Disease Council Chair for the International Society of Heart and Lung Transplantation.
MD: Case Western Reserve University, Cleveland, OH, 1997.
MPH: Saint Louis University, St. Louis, MO, 2004.
Residency: Pediatrics, Cleveland Clinic Foundation, Cleveland, OH, 1997-2000.
Fellowship: Pediatric Infectious Diseases, St. Louis Children’s Hospital, Washington Univeristy, St. Louis, MO, 2000-2003.
Certification: Pediatrics, 2000; Pediatric Infectious Diseases, 2003.
Danziger-Isakov LA, Sweet S, DelaMorena M, Mendeloff E, Huddleston CB, DeBaun MR. Epidemiology of bloodstream infections in the first year after pediatric lung transplantation. The Pediatr Infectious Disease Journal. 2005; 24(4):324-330.
Spivey JF, Singleton D, Sweet S, Storch GA, Hayashi RJ, Huddleston CB, Danziger-Isakov LA. Prolonged Prophylaxis Against Cytomegalovirus (CMV) With Ganciclovir To Diminish CMV Viremia in Pediatric Lung Transplant Recipients: A Phase II Pilot Study. Pediatric Transplantation. 2007;11(3):312-8.
Danziger-Isakov LA, Worley S, Arrigain S,Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Michaels MG, Michelson P, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. Increased Mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J Heart Lung Transplant. 2008; 27(6): 655-661.
Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A. The risk, prevention & outcome of cytomegalovirus after pediatric lung transplantation. Transplantation. 2009 May 27;87(10):1541-8.
Liu M, Worley S, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Michelson P, Mogayzel PJ, Parakinikas D, Visner G, Sweet S, Faro A, Michaels M, Danziger-Isakov LA. Respiratory Viral Infections within one year after Pediatric Lung Transplant. Transpl Infect Dis. 2009 Aug;11(4):304-12.
Ranganathan K, Worley S, Michaels MG, Arrigan S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB Jr, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet SC, Faro A, Danziger-Isakov L. Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation. J Heart Lung Transplant. 2009 Oct;28(10):1050-6.
Danziger-Isakov LA, Cherkassky L, Siegel H, McManamon M, Kramer K, Budev M, Sawinski D, Augustine JJ, Hricik DE, Fairchild R, Heeger PS, Poggio ED. Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation, 2010 Apr 15;89(7):838-44.
Cherkassky L, Lanning M, Lalli PN, Czerr J, Siegel H, Danziger-Isakov L, Srinivas T, Valujskikh A, Shoskes DA, Baldwin W, Fairchild RL, Poggio ED. Evaluation of Alloreactivity in Kidney Transplant Recipients Treated with Antithymocyte Globulin Versus IL-2 Receptor Blocker. Am J Transplant. 2011 Jul;11(7):1388-1396.
Moses J, Alkhouri N, Shannon A, Raig K, Lopez R, Danziger-Isakov L, Feldstein AE, Zein NN, Wyllie R, Carter-Kent C. Hepatitis B Immunity and Response to Booster Vaccination in Children With Inflammatory Bowel Disease Treated With Infliximab. Am J Gastroenterol. 2011 Aug 30.
Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant. 2012 Aug;31(8):839-44.
Viral triggers of alloimmunity and autoimmunity in pediatric lung transplantation. Co-Investigator. Protocol Chair, Steering Committee, NIH/NIAID, March 2008-Feb 2013. 1U01AI77810-01.
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (ARRA). Co-Investigator. Protocol Chair, Steering Committee, NIH/NIAID, Sep 2009-Aug 2013. 1 U01 AI077810-02S1.
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (ARRA), Perceived Barriers to Patient Adherence after Pediatric Solid Organ Transplantation. Co-Investigator. Protocol Chair, Steering Committee, NIH/NIAID, Sep 2010-Aug 2013. U01 AI077810-03S1.
Heidi J. Kalkwarf, PhD, RD
Calcium and bone metabolism; establishing nutrient requirements; calcium metabolism during lactation; bone mineral acquisition in children
Heidi Kalkwarf, PhD, RD, is a nutritional epidemiologist whose research interest is in the development of dietary recommendations to optimize health, particularly bone health.
She has conducted research, funded by the National Institutes of Health (NIH) and the United States Department of Agriculture (USDA), focusing on dietary calcium requirements of lactating women and the changes in bone density and in calcium metabolism that occur during lactation and after weaning. Dr. Kalkwarf's research has been published in the New England Journal of Medicine, and was used by the Institute of Medicine to establish the new dietary calcium intake recommendations for lactating women.
Dr. Kalkwarf also is investigating the normal patterns of bone growth and development in children and adolescents. The goals of this work are to identify the short term and long term consequences of low bone density in childhood, identify children who are at risk for osteoporosis later in life and to identify interventions to reduce this risk.
Dr. Kalkwarf came to Cincinnati Children's Hospital Medical Center as a postdoctoral fellow in 1990 and joined the faculty in 1993. She earned her master's and doctoral degrees in Nutritional Sciences at Cornell University in Ithaca, NY.
Copeland KA, Sherman SN, Khoury JC, Foster KE, Saelens BE, Kalkwarf HJ. Wide Variability in Physical Activity Environments and Weather-Related Outdoor Play Policies in Child Care Centers Within a Single County of Ohio. Arch Pediatr Adolesc Med. 2011 May;165(5):435-42.
Kalkwarf HJ, Laor T, Bean JA. Fracture risk in children with a forearm injury is associated with volumetric bone density and cortical area (by peripheral QCT) and areal bone density (by DXA). Osteoporos Int. 2011 Feb;22(2):607-16
Wosje KS, Khoury PR, Claytor RP, Copeland KA, Hornung RW, Daniels SR, Kalkwarf HJ. Dietary patterns associated with fat and bone mass in young children. Am J Clin Nutr. 2010 Aug;92(2):294-303.
Anderson JB, Beekman RH 3rd, Eghtesady P, Kalkwarf HJ, Uzark K, Kehl JE, Marino BS. Predictors of poor weight gain in infants with a single ventricle. J Pediatr. 2010 Sep;157(3):407-13, 413.e1.
Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Hangartner TN, Huang X, Frederick MM, Winer KK, Zemel BS. Tracking of bone mass and density during childhood and adolescence. J Clin Endocrinol Metab. 2010 Apr;95(4):1690-8.
Copeland KA, Sherman SN, Kendeigh CA, Saelens BE, Kalkwarf HJ. Flip flops, dress clothes, and no coat: clothing barriers to children's physical activity in child-care centers identified from a qualitative study. Int J Behav Nutr Phys Act. 2009 Nov 6;6:74.
Anderson JB, Beekman RH 3rd, Border WL, Kalkwarf HJ, Khoury PR, Uzark K, Eghtesady P, Marino BS. Lower weight-for-age z score adversely affects hospital length of stay after the bidirectional Glenn procedure in 100 infants with a single ventricle. J Thorac Cardiovasc Surg. 2009 Aug;138(2):397-404.e1.
Dorn LD, Susman EJ, Pabst S, Huang B, Kalkwarf H, Grimes S. Association of depressive symptoms and anxiety with bone mass and density in ever-smoking and never-smoking adolescent girls. Arch Pediatr Adolesc Med. 2008 Dec;162(12):1181-8.
Wosje KS, Khoury PR, Claytor RP, Copeland KA, Kalkwarf HJ, Daniels SR. Adiposity and TV viewing are related to less bone accrual in young children. J Pediatr. 2009 Jan;154(1):79-85.e2.
Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA. The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab. 2007 Jun;92(6):2087-99.
Impact of peripubertal exposure to xenohormones on fat distribution and cytokines. Co-investigator. National Institutes of Health. Apr 2010 - Mar 2012. #R21 ES017315-01A1. Cincinnati Center for Clinical and Translational Sciences and Training Grant. Co-investigator. National Institutes of Health. Apr 2009 - Mar 2013. #UL1 RR026314-01.
Impact of peripubertal exposure to xenohormones on fat distribution and cytokines. Co-investigator. National Institutes of Health. Apr 2010 - Mar 2012. #R21 ES017315-01A1.
Cincinnati Center for Clinical and Translational Sciences and Training Grant. Co-investigator. National Institutes of Health. Apr 2009 - Mar 2013. #UL1 RR026314-01.
Co-investigator. National Institutes of Health. Apr 2009 - Mar 2013. #UL1 RR026314-01.
Continued studies of environment impact on puberty. Co-investigator. National Institutes of Health. Sep 2001 - Apr 2015. #U01 ES019453-0.
Genome Wide Association Study of Bone Mineral Accretion during Childhood. Co-investigator (Principal investigator of sub-contract).National Institutes of Health. Fen 2010 - Jan 2015. #R01 HD058886-01A2.
Scott W. Powers, PhD, ABPP Director, Office for Clinical and Translational Research
Director, Office for Clinical and Translational Research
Co-Director, Headache Center
Director, Center for Child Behavior and Nutrition Research and Training
Director, Behavioral Science Core, Clinical Translational Research Center
Clinical trials; migraine/headache; pediatric pain; dietary adherence/nutrition and behavior; cystic fibrosis
Visit the Powers Lab.
AB: Wabash College, Crawfordsville, IN, 1985.
MS: Idaho State University, Pocatello, ID, 1987.
PhD: The University of Alabama, Tuscaloosa, AL, 1991.
Residency: Clinical Psychology, Brown University School of Medicine, Providence, RI.
Fellowship: Pediatric Psychology, Brown University School of Medicine / Rhode Island Hospital, Providence, RI.
Certification: Clinical Psychology, Ohio State Board of Psychology, 1992. American Board of Professional Psychology (ABPP), 2003.
Xiang, J., deGrauw, X., Korman, A.M., Allen, J.R., O’Brien, M.A., Powers, S.W., Hershey, A.D. Altered Cortical Activation in Adolescents with an Acute Migraine: A Magnetoencephalography Study. Journal of Pain, in press
Hershey, A.D., Powers, S.W., Coffey, C.S., Eklund, D.D., Chamberlin, L.A., Korbee, L.L.; CHAMP Study Group. Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Double-Blinded, Placebo-Controlled, Comparative Effectiveness Study of Amitriptyline, Topiramate, and Placebo in the Prevention of Childhood and Adolescent Migraine. Headache, 53(5):799-816. May, 2013.
Kashikar-Zuck S,Sil S, Lynch-Jordan AM, Ting TV, Peugh J, Schikler KR, Hashkes PJ, Arnold LM, Passo MH, Richards MM, Powers SW, Lovell D. Changes in pain coping, catastrophizing and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. The Journal of Pain, 14(5):492-501. May 2013.
Patton SR, Dolan LM, Chen M, Powers SW. Dietary Adherence and Mealtime Behaviors in Young Children with Type 1 Diabetes on Intensive Insulin Therapy. Journal of the Academy of Nutrition and Dietetics, 113(2):258-62. Feb, 2013.
Kashikar-Zuck S, Zafar M, Barnett KA, Aylward BS, Strotman D, Slater SK, Allen JR, LeCates SL, Kabbouche MA, Ting TV, Hershey AD, Powers SW. Quality of life and emotional functioning in youth with chronic migraine and juvenile fibromyalgia. Clinical Journal of Pain, Feb, 2013.
Patton SR, Dolan LM, Powers SW. Does Eating During Television Viewing Affects Mealtime Behaviors in Young Children with Type 1 Diabetes Mellitus? Journal of Pediatric Nursing,doi:pii: S0882-5963(12)00326-0. 0.1016/j.pedn.2012.11.007. Dec, 2012.
Brannon EB, Kuhl ES, Benoit MR, Valenzuela J, Aylward B, Johnson SL, Boles RE, Powers SW. Strategies for Recruitment and Retention of Families from Low-Income and Minority Backgrounds in a Longitudinal Study of Caregiver Feeding and Child Weight. Children’s Health Care, 2012, in press.
Guo X, Xiang J, Wang Y, O'Brien H, Kabbouche M, Horn P, Powers SW, Hershey AD Aberrant neuromagnetic activation in the motor cortex in children with acute migraine: a magnetoencephalography study. PLoS One ,2012, 7(11):e50095.
Slater SK, Kashikar-Zuck SM, Allen JR, Lecates SL, Kabbouche MA, O'Brien HL, Hershey AD, Powers SW. Psychiatric comorbidity in pediatric chronic daily headache. Cephalalgia,32(15): 1116-22. Nov, 2012.
Slater SK, Powers SW. Editorial on "Behavioral and emotional symptoms and primary headaches in children: A population-based study" by Arruda and Bigal. Cephalalgia,32(15): 1091-2. Nov, 2012.
Amitriptyline and Topiramate in the Prevention of Childhood Migraine. Principal Investigator, National Institute of Health and National Institute of Neurological Disorders and Stroke. Dec 2011 - Dec 2016. #1U01NS076788-01.
Adolescent Migraine and Hormones. Co-Investigator, National Headache Foundation (Subcontract from University of Cincinnati). 2012-2014
NeuroNEXT: Neurological Trials Network. Co-Investigator, University of Cincinnati and Cincinnati Children’s Clinical Site (NIH/NINDS). 2012-2017
Cincinnati Translational Therapeutics Development Network Center. Co-Investigator. Cystic Fibrosis Foundation. Jan 2009 - Jan 2014. Longitudinal Determination of Outcomes of Adolescents with Fibromyalgia. Co-Investigator. National Institute of Arthritis and Musculoskeletal and Skin Disorders. Aug 2009 - Aug 2014. #R01 AR054842-A2.
Clinical and Translational Science Award (CTSA). Co-Director of Behavioral Science Core, National Center for Research Resources. Apr 2009 - Mar 2014. #UL1 RR026314. Research Training in Child Behavior and Nutrition. Principal Investigator /Program Director. National Institute of Diabetes and Digestive and Kidney Diseases. Jul 2008 - Jul 2013. #T32 DK 063929-06.
Motor cortex dysfunction in migraine. Co-Investigator, National Institute of Health and National Institute of Neurological Disorders and Stroke. Dec 2010 – Dec 2012 No cost extension 2013) #R21NS072817-01.
Web-based delivery of effective treatment for growth in CF. Co-Investigator, CCHMC Place Outcomes Research Award. Jul 2011 – Jul 2013.
Lori J. Stark, PhD, ABPP Director, Behavioral Medicine and Clinical Psychology
Director, Behavioral Medicine and Clinical Psychology
Interim Director, Division of Developmental and Behavioral Pediatrics
Health psychology; anxiety; behavior problems; parent training; adherence to medical regimen; coping with illness; behavioral intervention
Visit the Stark Lab.
Lori Stark, PhD, joined Cincinnati Children's Hospital Medical Center in 1998 as the director of Psychology.
Dr. Stark is an authority on parenting of young children. She has applied this expertise to the area of health psychology by working with parents and children to improve their adherence to medical regimes, improving coping with chronic conditions or acute stressors, and providing biobehavioral interventions to conditions such as chronic pain.
Dr. Stark's work is unique in that it utilizes behavioral and environmental interventions to enhance healthcare outcome in pediatrics. Dr. Stark's expertise is on improving nutritional outcome in children with chronic conditions such as cystic fibrosis.
Dr. Stark has received continuous funding from the Cystic Fibrosis Foundation and the National Institute of Health to develop and evaluate behavioral interventions and improving nutritional outcome in children with cystic fibrosis.
Dr. Stark came to Cincinnati Children's Hospital Medical Center from Brown University School of Medicine where she was director of Pediatric Psychology at Rhode Island Hospital and associate professor of Psychiatry in Human Behavior at Brown University School of Medicine. Dr. Stark earned her undergraduate degree at Boston University and her graduate degree at West Virginia University.
Dr. Stark is on the Executive Committee of the Society of Pediatric Psychology, a division within the American Psychological Association. She has written many professional publications in the field of pediatric psychology and serves on the editorial board of the Journal of Pediatric Psychology and the Journal of Applied Behavior Analysis.
PhD: West Virginia University, Morgantown, WV, 1985.
Internship: Clinical Psychology, University of Mississippi Medical Center, Jackson, MS, 1984-1985.
Certification: Clinical Psychology, 1985.
Elaine M. Urbina, MD, MS Director, Preventive Cardiology
Director, Preventive Cardiology
Elaine M. Urbina, MD, graduated from the Medical College of Georgia in 1988. She subsequently trained in Pediatrics at the University of California at San Francisco. She completed her Pediatric Cardiology fellowship at Tulane University in New Orleans, Louisiana, in 1994 where she accepted an assistant professor position.
In addition to practicing clinical Pediatric Cardiology at Tulane, she was also director of Preventive Cardiology and the Pediatric Echocardiography Laboratory. Her research interests led her to join the world-renowned Bogalusa Heart Study, one of the longest running epidemiologic studies of CV risk factors in children. As co-investigator under the tutelage of Dr. Gerald S. Berenson, she initiated the non-invasive imaging program and supervised collection of CV data for over a decade.
Dr. Urbina joined Cincinnati Children's Hospital Medical Center as associate professor in October of 2003 and became director of Preventive Cardiology in 2006. This new opportunity allowed her to concentrate her clinical practice on the diagnosis and treatment of high blood pressure and cholesterol. She continues her research studies concentrating on non-invasive imaging methods to measure atherosclerosis with a focus on vascular function abnormalities using the modalities of:
Her current research includes the application of these new techniques to study the roles that pre- and post-natal nutrition, overweight, high blood pressure, cholesterol and diabetes play in the development of hardening of the arteries.
MD: Medical College of Georgia, Augusta, GA, 1988.
Residency: University of California, San Francisco, CA, 1990; Tulane University, New Orleans, LA 1991 (Pediatrics).
Fellowship: Tulane University, New Orleans, LA, 1994 (Pediatric Cardiology).
Certification: Pediatrics 1991; Pediatric Cardiology 1994.
Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens (Greenwich). May 2011;13(5):332-342.
Urbina EM, Dolan LM, McCoy CE, Khoury PR, Daniels SR, Kimball TR. Relationship between elevated arterial stiffness and increased left ventricle mass in adolescents and young adults. J Pediatr. May 2011;158(5):715-721.
Urbina EM, Kimball TR, Khoury PR, Daniels SR, Dolan LM. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. Aug 2010;28(8):1692-1698.
Urbina EM, Wadwa RP, Davis C, Snively BM, Dolan LM, Daniels SR, Hamman RF, Dabelea D. Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex. J Pediatr. May 2010;156(5):731-737.
Urbina EM, Kimball TR, McCoy CE, Khoury PR, Daniels SR, Dolan LM. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. Jun 2009;119(22):2913-2919.
Urbina EM, Bean JA, Daniels SR, D’Alessio D, Dolan LM. Overweight and hyperinsulinemia provide individual contributions to comprises in brachial artery distensibility in healthy adolescents and young adults: brachial distensibility in children. J Am Soc Hypertens. Jun 2007;1(3):200-207.
Urbina EM, Kieltkya L, Tsai J, Srinivasan SR, Berenson GS. Impact of multiple cardiovascular risk factors on brachial artery distensibility in young adults: The Bogalusa Heart Study. Am J Hypertens. Jun 2005;18:767-771.
Urbina EM, Srinivasan SR, Kieltyka RL, Tang R, Bond MG, Chen W, Berenson GS. Correlates of carotid artery stiffness in young adults: The Bogalusa Heart Study. Atherosclerosis. Sep 2004;176(1):157-164.
Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults: The Bogalusa Heart Study. Am J Cardiol. Nov 2002;90(9):953-958.
Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity and blood pressure of the left ventricular growth in children and young adults in Bogalusa Heart Study. Circulation. May 1995;91(9):2400-2406.
Accelerated CV Aging in Youth Related to CV Risk Factor Clusters. Principal Investigator. National Heart, Lung and Blood Institute. Jan 2011-Dec 2016.
SEARCH 3: Cohort Study - Ohio site. Co-Investigator. Centers for Disease Control & National Institutes of Health. Sept 2010-Oct 2015.
Cardiovascular Effects of Dietary Fat & Exercise Challenges in Obese Children. Collaborator. National Heart, Lung and Blood Institute. June 2008-May 2013.
Modifying Dietary Behavior in Adolescents with Elevated Blood Pressure. Co-Investigator. Natonal Heart, Lung and Blood Institute. Dec 2007-Nov 2012.
Rachel Baker, RN, PhD Research Associate
Becca Harper, RN, MSN Clinical Research Manager (Research Nurse Core)
Amy Hartkemeyer Business Manager
Theresa Kenney Biochemistry Core Lab Supervisor
Suzanne Summer, MS, RD, LD Clinical Research Manager (Bionutrition and Body Composition Core)
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center